http://rdf.ncbi.nlm.nih.gov/pubchem/reference/20824245
Outgoing Links
Predicate | Object |
---|---|
contentType | Journal Article |
endingPage | 13 |
issn | 1687-918X 1687-9198 |
pageRange | 386410-13 |
publicationName | International Journal of Microbiology |
startingPage | 386410 |
bibliographicCitation | Lohans CT, Vederas JC. Development of Class IIa Bacteriocins as Therapeutic Agents. International Journal of Microbiology. 2012;2012():1–13. doi: 10.1155/2012/386410. |
creator | http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_888e020d41b55a5a986e9b049375c894 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0489c9ee1b85380e77f1438776c84721 |
date | 2012 |
identifier | https://pubmed.ncbi.nlm.nih.gov/22187559 https://doi.org/10.1155/2012/386410 https://pubmed.ncbi.nlm.nih.gov/PMC3236453 |
isPartOf | http://rdf.ncbi.nlm.nih.gov/pubchem/journal/36665 https://portal.issn.org/resource/ISSN/1687-9198 https://portal.issn.org/resource/ISSN/1687-918X |
language | English |
source | https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/ |
title | Development of Class IIa Bacteriocins as Therapeutic Agents |
Incoming Links
Total number of triples: 41.